Jeuveau® Now Available Through Pipeline Medical
Want more reasons to smile? At Pipeline Medical, we are pleased to offer you unparalleled benefits on Jeuveau®. With us, you get:
- Exclusive pricing
- Free training
- Free samples
- Marketing Collaboration
- Increased Profitability
- Reduced Procedural Costs
Developed With Hi-Pure™ Technology
Ready To Uncover Precision With Jeuveau®
Jeuveau® is the most precise neurotoxin available. It acts like the other leading neurotoxins but is long lasting and has a short "therapeutic window" quick onset of action. It is proven effective in as little as 2 days and as long as 4 months.
No More Lines With Jeuveau®
Every vial of Jeuveau® comes packed with precision
Jeuveau® puts control of fast-acting, long-lasting intramuscular results in the hands of the provider. After 30 days, over 94% of patients said they felt "much improved" or "improved," and you know what: numbers don't lie.
Ready to Uncover Precision With Jeuveau®?
Frown lines are now avoidable because Jeuveau® is affordable
70% of U.S. patients using Jeuveau® saw a 2-grade or better improvement in frown lines after 30 days. Get deeper quarterly discounts and more marketing benefits. Pipeline Medical is pleased to announce that we now offer Jeuveau®, by Evolus, at an exclusively low price for Pipeline customers.
- Providing the least expensive toxin in the market compared to other neurotoxins.
- $40 off each treatment when your patient signs up for the reward program.
- Complimentary marketing program, free training and samples for YOU.
Now That You Have Jeuveau® Looking Young Is Possible
Real World Patient Satisfaction
Backed By Clinical Data
FDA-approved 900-kDa neurotoxin; Jeuveau® has proven its efficacy for desired results. The modern-made neurotoxin was released in 2019 to reduce wrinkles proved by studies on over 2,100 subjects in 5 clinical trials.
67.5%
(EV 001) for Jeuveau®
Only 1.2% of patients showed positive results in the placebo group compared to Jeuveau® where 67.5% showed results.
70%
(EV002) for Jeuveau®
Only 1.3% of patients showed positive results in the placebo arm compared to the Jeuveau® group 70% showed results.
Got questions?
Contact us right away and give us
the opportunity to assist you
We prioritize customer service
